These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19524179)

  • 1. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
    Bielsa S; Esquerda A; Salud A; Montes A; Arellano E; Rodríguez-Panadero F; Porcel JM
    Eur J Intern Med; 2009 Jul; 20(4):383-6. PubMed ID: 19524179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
    Singh SK; Bhargava R; Gupta V
    Eur J Intern Med; 2009 Nov; 20(7):e147. PubMed ID: 19818283
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ; De Miguel J; García Díaz JD; Díez M
    Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
    Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
    Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
    Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
    Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
    Son SM; Han HS; An JY; Choe KH; Lee KM; Lee KH; Kim SS; Lee YM; Lee HC; Song HG; Lee OJ
    Pathology; 2015 Feb; 47(2):123-9. PubMed ID: 25551300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma.
    Suzuki H; Hirashima T; Kobayashi M; Sasada S; Okamoto N; Uehara N; Tamiya M; Matsuura Y; Morishita N; Kawase I
    Anticancer Res; 2010 Oct; 30(10):4343-6. PubMed ID: 21036761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.